A Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.
| Autor: | Cohen S; Internal Medicine, Rheumatology Division, Metroplex Clinical Research Center, Dallas, TX, USA. arthdoc@aol.com., Akmaev VR; Scipher Medicine, Waltham, MA, USA., Withers JB; Scipher Medicine, Waltham, MA, USA., Connolly-Strong E; Scipher Medicine, Waltham, MA, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Rheumatology and therapy [Rheumatol Ther] 2022 Feb; Vol. 9 (1), pp. 309-311. Date of Electronic Publication: 2021 Nov 10. |
| DOI: | 10.1007/s40744-021-00387-9 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |